Anteris Technologies Glob... (AVR)
Anteris Technologies Global Corp. (AVR) Stock Price, Analysis & Data
| Bid | 5.95 |
| Market Cap | 892.63M |
| Revenue (ttm) | 1.85M |
| Net Income (ttm) | -95.3M |
| Beta | 0.73 |
| EPS (ttm) | -1.95 |
| PE Ratio (ttm) | n/a |
| Forward PE | -9.36 |
| P/B (ttm) | 3.20 |
| P/S (ttm) | 482.24 |
| Earnings Date | Aug 14, 2026 |
| Ask | 10.57 |
| Volume | 1,081,284 |
| Avg. Volume (20D) | 1,293,853 |
| Open | 9.02 |
| Previous Close | 8.96 |
| Day's Range | 9.00 - 9.46 |
| 52-Week Range | 3.30 - 11.05 |
| Analyst | n/a |
| Price Target | 15 (63.58%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AVR
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification prepa...
Financial Performance
In 2023, Anteris Global's revenue was 2.73M, a decrease of -14.56% compared to the previous year's 3.2M. Earnings were -46.02M, an increase of 50.58%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for AVR stock is "null". The 12-month stock price forecast is 15, which is upside of 63.58% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
